Pediatrics ITP,
Bleeding, and
Child abuse
Immune Thrombocytopenia
(ITP)
01
Definition of
Thrombocytopenia
• Platelet count <150,000/μL
• Often found incidentally or during bleeding/bruising work-
up
• Immune-mediated processes are the most common causes
in children
ITP
• Most common cause of isolated thrombocytopenia in
children
• Peak age: 2–5 years
• Sudden bruising, petechiae, or mucosal bleeding
• Often post-viral or post-vaccine, but many cases idiopathic
• Primary ITP: No associated systemic disease
• Secondary ITP: Associated with SLE, HIV, CVID, ALPS, drugs
• By Duration:
• Newly diagnosed: <3 months
• Persistent: 3–12 months
• Chronic: >12 months
Pathogenesis
• Autoantibodies (IgG) against GP IIb/IIIa, Ib/IX, etc.
• Antibody-coated platelets macrophage clearance (mainly
→
spleen)
• Antibodies may also impair megakaryocyte function
• Involvement of T-cell cytotoxicity and immune
dysregulation (Tregs/B-cells)
Epidemiology
• Annual incidence: 1–6.4/100,000 children
• Underdiagnosed due to asymptomatic or mild cases
• Peak: 2–5 years, minor secondary peak in adolescence
Clinical Presentation
• Healthy-appearing child with:
• Sudden petechiae, purpura, bruising
• ± mucosal bleeding (epistaxis, oral, GU, GI)
• Often preceded by viral illness or MMR vaccination
• Systemic signs absent (no fever, bone pain, hepatosplenomegaly)
Bleeding Severity
• Most have mild mucocutaneous bleeding
• 40% have mucosal bleeding
• Serious bleeding: ~3%
• Intracranial hemorrhage (ICH): <1%
• High risk if platelets <10,000/μL
Diagnostic
evaluation
• CBC with differential
• Peripheral blood smear
• Reticulocyte count
• Direct antiglobulin test
• Immunoglobulin levels
Further tests if atypical findings
Diagnostic Criteria
• Platelets <100,000/μL
• Normal CBC, normal smear
• No systemic symptoms
• Diagnosis of exclusion
Note: Antiplatelet antibody testing not helpful (low
sensitivity/specificity)
Differential Diagnosis
• Malignancies (ALL, lymphoma)
• Infections (EBV, HIV, CMV)
• Autoimmune diseases (SLE)
• Bone marrow failure syndromes
• DIC, TTP, HUS
• Drug-induced thrombocytopenia
• Inherited thrombocytopenia
Management
• Observation for mild/no bleeding
• Treat if:
• Platelets <10,000/μL
• Mucosal or life-threatening bleeding
• First-line: IVIG, anti-D (if Rh+), or steroids
• Reserve platelet transfusions for emergencies
Severe Bleeding
Management
• Platelet transfusions: 10–30 mL/kg bolus
• IVIG + Steroids ± anti-D
• Add TPO-RA (romiplostim) to sustain counts
• Consider ICU admission for ICH or GI hemorrhage
Disease Course
• 80–90% recover in 3–6 months
• 10–20% chronic ITP (>12 months)
→
• Risk factors for chronicity:
• Older age
• No preceding infection
• Less severe thrombocytopenia at diagnosis
• Insidious onset
Chronic ITP:
Management
• Avoid contact sports, NSAIDs
• Monitor labs and menstrual bleeding
• First-line: IVIG, steroids
• If recurrent/severe:
• TPO-RAs preferred
• Rituximab if autoimmune-associated
• Splenectomy rare (reserved, due to lifelong risks)
Prognosis
• 30% spontaneous remission by 2 years
• 50% remission by 5 years
• Severe bleeding <10% over 5 years
• Younger age = better prognosis
Bleeding in Children
02
Approach to Pediatric Bleeding
● Begin with a focused history
● Follow with targeted physical exam
● Order baseline labs based on findings
● Use structured tools like bleeding assessment scores
Focused History
● Onset and frequency of bleeding
● Triggering events (trauma, surgery, dental work)
● Type of bleeding: mucosal vs deep tissue
● Past medical history, meds, supplements
● Family history of bleeding disorders
● Possible child abuse in unexplained bruising
Bleeding Assessment Tools
● ISTH Bleeding Assessment Tool (BAT)
○ Score 3 further evaluation needed
≥ →
● Helps quantify symptoms and guide testing
● Use when the history is unclear or symptoms vague
Child Abuse Considerations
● Pattern and location of bruises inconsistent with history
● Multiple stages of healing
● Delay in seeking care
● Consider abuse in any atypical bruising without coagulopathy
Initial Lab Work-Up
● CBC + Platelet count
● Peripheral smear
● Prothrombin time (PT)
● Activated partial thromboplastin time (aPTT)
● Fibrinogen
● Von Willebrand panel:
○ VWF antigen
○ VWF activity
○ Factor VIII level
Diagnostic Approach
● Use initial lab results to narrow causes
● Algorithm-based evaluation is recommended
● Examples:
○ ↓ Platelets: consider ITP, leukemia, DIC
○ Normal platelets + PT/aPTT: consider factor
↑
deficiencies
○ Normal PT/aPTT + mucosal bleeding: think VWD
Further Testing
● Based on initial findings, consider:
● Coagulation factor assays (VIII, IX, XI, XIII)
● Platelet function testing (e.g., aggregation studies)
● Antiphospholipid antibodies
● Thrombin time (TT), factor XIII activity
● Fibrinolysis evaluation (e.g., D-dimer, euglobulin clot lysis time)
Child Abuse
03
Definition
● Injury inflicted upon a child by a caregiver or parent
● Legal and cultural definitions may vary
● Key: Inflicted, not accidental trauma
Epidemiology
● Thousands of injuries and deaths annually worldwide
● High risk of repeated harm if not intervened
● Early recognition = lifesaving
● Most common in children under 5 years
Approach to Suspected Abuse
● Keep abuse in differential diagnosis of any unexplained
injury
● Carefully assess:
○ History: inconsistency, delay in care
○ Physical exam: patterned injuries, fractures
● Involve child protection teams when possible
● Report any suspicion to child services
Risk Factors
(Contextual, Not Diagnostic)
● Young age
● Household history of abuse
● Family stress, poverty, isolation
● Caregiver mental illness or substance use
● Race or socioeconomic status should NOT be used to guide
suspicion
Red Flag History for Abuse
● Injury inconsistent with developmental stage
● Vague or changing history
● Delay in seeking medical attention
● Recurrent injuries with no clear cause
● Explanation not matching injury severity
Red Flag History for Abuse
Red Flag Physical Exam Findings
● Bruises in non-mobile infants
● Patterned or clustered bruises
● Burns (e.g., immersion, cigarette)
● Retinal hemorrhages
● Multiple fractures in various healing stages
● Genital or perianal injuries
When to Pursue Full Work-Up
● Presence of any red flag history or exam finding
● Use institutional abuse protocol (lab + imaging)
● Refer to child protection team or abuse specialist
● Transfer if specialized services are not available
Screening
Recommendations
• ED/urgent care: Routine screening for <5 years recommended
• Increases detection
• Reduces missed cases
• Use validated tools
• Requires institutional commitment and team collaboration
Primary Care
Limitations
• Universal screening not yet supported by evidence
• Rely on clinical vigilance + family dynamics assessment
• Incorporate abuse awareness into developmental visits
Thank
You!

ITP Bleeding Case Powerpoint Presentation

  • 1.
  • 2.
  • 3.
    Definition of Thrombocytopenia • Plateletcount <150,000/μL • Often found incidentally or during bleeding/bruising work- up • Immune-mediated processes are the most common causes in children
  • 4.
    ITP • Most commoncause of isolated thrombocytopenia in children • Peak age: 2–5 years • Sudden bruising, petechiae, or mucosal bleeding • Often post-viral or post-vaccine, but many cases idiopathic • Primary ITP: No associated systemic disease • Secondary ITP: Associated with SLE, HIV, CVID, ALPS, drugs • By Duration: • Newly diagnosed: <3 months • Persistent: 3–12 months • Chronic: >12 months
  • 6.
    Pathogenesis • Autoantibodies (IgG)against GP IIb/IIIa, Ib/IX, etc. • Antibody-coated platelets macrophage clearance (mainly → spleen) • Antibodies may also impair megakaryocyte function • Involvement of T-cell cytotoxicity and immune dysregulation (Tregs/B-cells)
  • 7.
    Epidemiology • Annual incidence:1–6.4/100,000 children • Underdiagnosed due to asymptomatic or mild cases • Peak: 2–5 years, minor secondary peak in adolescence
  • 8.
    Clinical Presentation • Healthy-appearingchild with: • Sudden petechiae, purpura, bruising • ± mucosal bleeding (epistaxis, oral, GU, GI) • Often preceded by viral illness or MMR vaccination • Systemic signs absent (no fever, bone pain, hepatosplenomegaly)
  • 10.
    Bleeding Severity • Mosthave mild mucocutaneous bleeding • 40% have mucosal bleeding • Serious bleeding: ~3% • Intracranial hemorrhage (ICH): <1% • High risk if platelets <10,000/μL
  • 11.
    Diagnostic evaluation • CBC withdifferential • Peripheral blood smear • Reticulocyte count • Direct antiglobulin test • Immunoglobulin levels Further tests if atypical findings
  • 12.
    Diagnostic Criteria • Platelets<100,000/μL • Normal CBC, normal smear • No systemic symptoms • Diagnosis of exclusion Note: Antiplatelet antibody testing not helpful (low sensitivity/specificity)
  • 13.
    Differential Diagnosis • Malignancies(ALL, lymphoma) • Infections (EBV, HIV, CMV) • Autoimmune diseases (SLE) • Bone marrow failure syndromes • DIC, TTP, HUS • Drug-induced thrombocytopenia • Inherited thrombocytopenia
  • 14.
    Management • Observation formild/no bleeding • Treat if: • Platelets <10,000/μL • Mucosal or life-threatening bleeding • First-line: IVIG, anti-D (if Rh+), or steroids • Reserve platelet transfusions for emergencies
  • 16.
    Severe Bleeding Management • Platelettransfusions: 10–30 mL/kg bolus • IVIG + Steroids ± anti-D • Add TPO-RA (romiplostim) to sustain counts • Consider ICU admission for ICH or GI hemorrhage
  • 18.
    Disease Course • 80–90%recover in 3–6 months • 10–20% chronic ITP (>12 months) → • Risk factors for chronicity: • Older age • No preceding infection • Less severe thrombocytopenia at diagnosis • Insidious onset
  • 19.
    Chronic ITP: Management • Avoidcontact sports, NSAIDs • Monitor labs and menstrual bleeding • First-line: IVIG, steroids • If recurrent/severe: • TPO-RAs preferred • Rituximab if autoimmune-associated • Splenectomy rare (reserved, due to lifelong risks)
  • 20.
    Prognosis • 30% spontaneousremission by 2 years • 50% remission by 5 years • Severe bleeding <10% over 5 years • Younger age = better prognosis
  • 21.
  • 22.
    Approach to PediatricBleeding ● Begin with a focused history ● Follow with targeted physical exam ● Order baseline labs based on findings ● Use structured tools like bleeding assessment scores
  • 23.
    Focused History ● Onsetand frequency of bleeding ● Triggering events (trauma, surgery, dental work) ● Type of bleeding: mucosal vs deep tissue ● Past medical history, meds, supplements ● Family history of bleeding disorders ● Possible child abuse in unexplained bruising
  • 24.
    Bleeding Assessment Tools ●ISTH Bleeding Assessment Tool (BAT) ○ Score 3 further evaluation needed ≥ → ● Helps quantify symptoms and guide testing ● Use when the history is unclear or symptoms vague
  • 26.
    Child Abuse Considerations ●Pattern and location of bruises inconsistent with history ● Multiple stages of healing ● Delay in seeking care ● Consider abuse in any atypical bruising without coagulopathy
  • 27.
    Initial Lab Work-Up ●CBC + Platelet count ● Peripheral smear ● Prothrombin time (PT) ● Activated partial thromboplastin time (aPTT) ● Fibrinogen ● Von Willebrand panel: ○ VWF antigen ○ VWF activity ○ Factor VIII level
  • 28.
    Diagnostic Approach ● Useinitial lab results to narrow causes ● Algorithm-based evaluation is recommended ● Examples: ○ ↓ Platelets: consider ITP, leukemia, DIC ○ Normal platelets + PT/aPTT: consider factor ↑ deficiencies ○ Normal PT/aPTT + mucosal bleeding: think VWD
  • 29.
    Further Testing ● Basedon initial findings, consider: ● Coagulation factor assays (VIII, IX, XI, XIII) ● Platelet function testing (e.g., aggregation studies) ● Antiphospholipid antibodies ● Thrombin time (TT), factor XIII activity ● Fibrinolysis evaluation (e.g., D-dimer, euglobulin clot lysis time)
  • 31.
  • 32.
    Definition ● Injury inflictedupon a child by a caregiver or parent ● Legal and cultural definitions may vary ● Key: Inflicted, not accidental trauma
  • 33.
    Epidemiology ● Thousands ofinjuries and deaths annually worldwide ● High risk of repeated harm if not intervened ● Early recognition = lifesaving ● Most common in children under 5 years
  • 34.
    Approach to SuspectedAbuse ● Keep abuse in differential diagnosis of any unexplained injury ● Carefully assess: ○ History: inconsistency, delay in care ○ Physical exam: patterned injuries, fractures ● Involve child protection teams when possible ● Report any suspicion to child services
  • 35.
    Risk Factors (Contextual, NotDiagnostic) ● Young age ● Household history of abuse ● Family stress, poverty, isolation ● Caregiver mental illness or substance use ● Race or socioeconomic status should NOT be used to guide suspicion
  • 36.
    Red Flag Historyfor Abuse ● Injury inconsistent with developmental stage ● Vague or changing history ● Delay in seeking medical attention ● Recurrent injuries with no clear cause ● Explanation not matching injury severity
  • 37.
  • 39.
    Red Flag PhysicalExam Findings ● Bruises in non-mobile infants ● Patterned or clustered bruises ● Burns (e.g., immersion, cigarette) ● Retinal hemorrhages ● Multiple fractures in various healing stages ● Genital or perianal injuries
  • 41.
    When to PursueFull Work-Up ● Presence of any red flag history or exam finding ● Use institutional abuse protocol (lab + imaging) ● Refer to child protection team or abuse specialist ● Transfer if specialized services are not available
  • 42.
    Screening Recommendations • ED/urgent care:Routine screening for <5 years recommended • Increases detection • Reduces missed cases • Use validated tools • Requires institutional commitment and team collaboration
  • 43.
    Primary Care Limitations • Universalscreening not yet supported by evidence • Rely on clinical vigilance + family dynamics assessment • Incorporate abuse awareness into developmental visits
  • 44.